Effects of Dexmedetomidine combined with Pentazocine on postoperative inflammatory response and hypercoagulability in elderly patients underwent total hip replacement
LI Guangwei DONG Fusheng
Department of Anesthesia, the Second Hospital of Qinhuangdao, Hebei Province, Qinhuangdao 066600, China
Abstract：Objective To study the effect of Dexmedetomidine combined with Pentazocine on postoperative inflammatory response and hypercoagulability in elderly patients underwent total hip replacement. Methods From May 2016 to May 2017, 300 elderly patients who underwent total hip replacement in the Second Hospital of Qinhuangdao were selected as the study subjects. The patients were divided into study group and control group by random number table method, with 150 cases in each group. The control group was treated with Pentazocine for analgesic treatment, and the study group was treated with Dexmedetomidine combined with Pentazocine for analgesic treatment. The postoperative inflammatory response, hypercoagulability, postoperative pain at different time and adverse reactions were compared between the two groups. Results There were no significant differences in serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) between the two groups at immediate preoperative and immediate postoperative (P ＞ 0.05), the levels of IL-6 and TNF-α in the two groups at immediate postoperative and postoperative 24 hours were significantly higher than those at immediate preoperative, but the levels of IL-6 and TNF-α in the study group were lower than those in the control group at postoperative 24 hours, the differences were statistically significant (P ＜ 0.05). There were no significant differences in the levels of D-dimer and fibrinogen (Fib) between the two groups at immediate preoperative and immediate postoperative (P ＞ 0.05), the levels of D-dimer and Fib in the two groups at immediate postoperative and postoperative 24 hours were significantly higher than those at immediate preoperative, but the levels of D-dimer and Fib in the study group were lower than those in the control group at postoperative 24 hours, the differences were statistically significant (P ＜ 0.05). Visual analogue scale (VAS) scores in the study group were significantly lower than those in the control group at postoperative 6, 12, 24 hours (P ＜ 0.05). The incidence of gastrointestinal reactions and vertigo in the study group were significantly lower than those in the control group (P ＜ 0.05), and there was no significant difference in the incidence of hypertension between the two groups (P ＞ 0.05). Conclusion Dexmedetomidine combined with Pentazocine can effectively improve the inflammatory response and hypercoagulability in elderly patients underwent total hip replacement, and effectively alleviate the pain, and also has a good safety.
李广伟 董福生. 右美托咪定复合喷他佐辛对全髋关节置换老年患者术后炎性反应及高凝状态的影响[J]. 中国医药导报, 2019, 16(7): 105-108.
LI Guangwei DONG Fusheng. Effects of Dexmedetomidine combined with Pentazocine on postoperative inflammatory response and hypercoagulability in elderly patients underwent total hip replacement. 中国医药导报, 2019, 16(7): 105-108.
[1] Messori A，Trippoli S，Marinai C，et al. Handling the procurement of prostheses for total hip replacement：description of an original value based approach and application to a real-life dataset reported in the UK [J]. BMJ Open，2017，7（12）：18603-18604.
[2] 邓艳玲，薛慕.不同剂量右美托咪定在老年髋关节置换术中的应用研究[J].医学信息，2015，28（46）：101-102.
[3] 胡琼，张柏银.股神经阻滞麻醉联合硬膜外自控镇痛在全膝关节置换术后的镇痛效果评价[J].海军医学杂志，2014，35（4）：271-273.
[4] 刘沁爽，孙东辉，戚小航，等.不同剂量盐酸右美托咪定对全髋关节置换术后老年患者术后早期认知功能的影响[J].河北医药，2015，32（24）：3745-3747.
[5] 李航，刘强，陈建平，等.右美托咪定在老年椎管内麻醉中对麻黄碱升压作用的影响[J].中华老年骨科与康复电子杂志，2016，2（4）：234-238.
[6] Vicenti G，Pesce V，Bizzoca D，et al. Perioperative plasmatic presepsin levels in patients undergoing total hip or knee replacement：a preliminary study [J]. J Biol Regul Homeost Agents，2017，31（4）：1081-1086.
[7] 阳涛，杨艳，张霞，等.硝酸甘油联合右美托咪定在老年患者全髋关节置换术中的控制性降压效果[J].临床合理用药杂志，2015，9（27）：123-125.
[8] 谢鹃，施海滨，朱彬，等.右美托咪定对老年患者全髋关节置换术后认知功能障碍的影响[J].浙江创伤外科，2014， 19（2）：334-335.
[9] 吴毅，徐辉，郭明炎，等.术中静脉不同剂量右美托咪啶对全髋置换术患者术后患者芬太尼静脉自控镇痛效果的影响[J].现代生物医学进展，2014，14（26）：5088-5091.
[10] 杨艳琴.右美托咪定对老年性全髋关节置换术患者小剂量布比卡因腰麻的影响[J].中华临床医师杂志：电子版，2015，9（13）：2516-2520.
[11] 杨琳，程平瑞，江伟航，等.氟比洛芬酯复合喷他佐辛静脉镇痛用于老年患者髋关节置换术后的效果[J].中日友好医院学报，2013，27（1）：34-35.
[12] 陈嫩红.右美托咪定复合丙泊酚对高龄患者行全髋关节置换术中血压、心率及苏醒时间的影响[J].现代诊断与治疗，2017，28（13）：2420-2422.
[13] 滕成玲，赵玉，吕德珍，等.右美托咪定联合依达拉奉对老年全髋关节置换术患者术后谵妄的影响[J].中国医药，2017，12（8）：1235-1238.
[14] 安仙泉，方美丹，王聪，等.右美托咪定与咪达唑仑复合腰硬联合麻醉对老年髋关节置换术患者早期认知功能和炎症因子的影响[J].中国老年学杂志，2017，37（2）：428-429.
[15] 储浩，张野，王胜斌，等.不同剂量右美托咪啶联合罗哌卡因髂筋膜间隙阻滞在全髋关节置换术中的应用[J].实用医学杂志，2017，33（10）：1673-1677.
[16] 曾德亮，章放香，余相地，等.不同浓度右美托咪定混合罗哌卡因连续腰丛神经阻滞用于老年患者髋关节置换术后镇痛效果的比较[J].中华麻醉学杂志，2017，37（1）：84-87.
[17] 杨帅，华丽，王雄，等.右美托咪定与布托啡诺用于老年全髋关节置换术后自控镇痛效果的比较[J].四川医学，2017，38（1）：36-39.
[18] 刘洋，高东艳.右美托咪定在老年骨科患者麻醉中的应用进展[J].中国现代医生，2018，56（15）：164-168.
[19] 韦秋凤，陈小健，冯丝丝，等.右美托咪定对全髋关节置换术患者脑氧代谢与能量代谢的影响[J].广西医科大学学报，2017，34（5）：743-745.
[20] 王大伟，郭清源，李世平，等.右美托咪定和咪达唑仑用于下肢手术术中的镇静效果观察[J].现代医院，2017， 17（8）：1217-1219.
[21] 赵晓英，白晓丽，武娟，等.右美托咪定联合舒芬太尼用于老年患者全髋关节置换术后自控静脉镇痛[J].国际麻醉学与复苏杂志，2017，38（6）：515-518.
[22] 王春光，丁彦玲，贾军，等.右美托咪定对罗哌卡因关节腔注射用于膝关节镜术后镇痛效果的影响[J].中国疼痛医学杂志，2014，20（8）：597-599.
[23] 房君，王瑞春，郑晋伟.右美托咪定对老年患者全髋关节置换术后早期睡眠质量的影响[J].中国现代医生，2018， 56（7）：93-96.
2019, Vol. 16 
京公网安备 11010502046598号